Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Improved treatment outcomes with bedaquiline when substituted for second-line injectable agents in multidrug-resistant tuberculosis: A retrospective cohort study
Background Bedaquiline is used as a substitute for second-line injectable (SLI) intolerance in the treatment of multidrug-resistant tuberculosis (MDR-TB), but the efficacy and safety of this strategy is unknown. Methods We performed a retrospective cohort study to evaluate treatment outcomes for MDR...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
Department of Medicine
2020
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Improved treatment outcomes with bedaquiline when substituted for second-line injectable agents in multidrug-resistant tuberculosis: A retrospective cohort study
- An analysis of the upstream supply chain for second-line drugs for multidrug-resistant tuberculosis
- A pharmacometric approach to optimal use of second line drugs for multidrug-resistant tuberculosis
- Sodium, potassium adenosine triphosphatase as a potential target of the anti-tuberculosis agents, clofazimine and bedaquiline
- Epidemiological impact of HIV on second - line drug resistance in patients with multidrug resistant tuberculosis in high HIV prevalent settings in South Africa
- Transmission of bedaquiline-resistant tuberculosis in the Western Cape Province, South Africa
- Ausceptibility testing and resistance mechanisms to second-line agents against Mycobacterium tuberculosis in Pretoria, South Africa